BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36314076)

  • 1. Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell-like property of glioblastoma cells.
    Ishikawa T; Ogura Y; Tanaka K; Nagashima H; Sasayama T; Endo M; Minami Y
    Cancer Sci; 2023 Feb; 114(2):561-573. PubMed ID: 36314076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
    Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
    Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The signaling pathways activated by ROR1 in cancer.
    Quezada MJ; Lopez-Bergami P
    Cell Signal; 2023 Apr; 104():110588. PubMed ID: 36621728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
    Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
    Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
    Endo M; Doi R; Nishita M; Minami Y
    J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells.
    Man J; Yu X; Huang H; Zhou W; Xiang C; Huang H; Miele L; Liu Z; Bebek G; Bao S; Yu JS
    Cell Stem Cell; 2018 Jan; 22(1):104-118.e6. PubMed ID: 29198941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
    Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
    J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.
    Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1.
    Islam SS; Uddin M; Noman ASM; Akter H; Dity NJ; Basiruzzman M; Uddin F; Ahsan J; Annoor S; Alaiya AA; Al-Alwan M; Yeger H; Farhat WA
    EBioMedicine; 2019 May; 43():211-224. PubMed ID: 31085100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1.
    Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y
    Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
    Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
    J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
    Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells.
    Hu YY; Zheng MH; Cheng G; Li L; Liang L; Gao F; Wei YN; Fu LA; Han H
    BMC Cancer; 2011 Feb; 11():82. PubMed ID: 21342503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling.
    Hu T; Xuan R; Han E; Cai L; Xia Z
    J Neurooncol; 2023 Aug; 164(1):157-170. PubMed ID: 37523046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.
    Mao XG; Yan M; Xue XY; Zhang X; Ren HG; Guo G; Wang P; Zhang W; Huo JL
    Lab Invest; 2011 Jul; 91(7):1068-78. PubMed ID: 21483406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway.
    Qiang L; Wu T; Zhang HW; Lu N; Hu R; Wang YJ; Zhao L; Chen FH; Wang XT; You QD; Guo QL
    Cell Death Differ; 2012 Feb; 19(2):284-94. PubMed ID: 21818118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis.
    Lin W; Niu R; Park SM; Zou Y; Kim SS; Xia X; Xing S; Yang Q; Sun X; Yuan Z; Zhou S; Zhang D; Kwon HJ; Park S; Il Kim C; Koo H; Liu Y; Wu H; Zheng M; Yoo H; Shi B; Park JB; Yin J
    Nat Commun; 2023 Mar; 14(1):1578. PubMed ID: 36949068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.